Buqing Sai

1.1k total citations · 1 hit paper
23 papers, 746 citations indexed

About

Buqing Sai is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Buqing Sai has authored 23 papers receiving a total of 746 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 9 papers in Oncology and 9 papers in Cancer Research. Recurrent topics in Buqing Sai's work include Cancer, Hypoxia, and Metabolism (4 papers), Cancer Cells and Metastasis (4 papers) and Cancer-related molecular mechanisms research (4 papers). Buqing Sai is often cited by papers focused on Cancer, Hypoxia, and Metabolism (4 papers), Cancer Cells and Metastasis (4 papers) and Cancer-related molecular mechanisms research (4 papers). Buqing Sai collaborates with scholars based in China, Saudi Arabia and Hong Kong. Buqing Sai's co-authors include Juanjuan Xiang, Lujuan Wang, Guiyuan Li, Leliang Zheng, Jingqun Tang, Xina Zhang, Fan Wang, Yuhui Wang, Yafei Dai and Zheng Li and has published in prestigious journals such as Advanced Materials, Journal of Biological Chemistry and Scientific Reports.

In The Last Decade

Buqing Sai

19 papers receiving 737 citations

Hit Papers

Hypoxic BMSC-derived exosomal miRNAs promote metastasis o... 2019 2026 2021 2023 2019 100 200 300 400

Peers

Buqing Sai
Buqing Sai
Citations per year, relative to Buqing Sai Buqing Sai (= 1×) peers Leliang Zheng

Countries citing papers authored by Buqing Sai

Since Specialization
Citations

This map shows the geographic impact of Buqing Sai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Buqing Sai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Buqing Sai more than expected).

Fields of papers citing papers by Buqing Sai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Buqing Sai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Buqing Sai. The network helps show where Buqing Sai may publish in the future.

Co-authorship network of co-authors of Buqing Sai

This figure shows the co-authorship network connecting the top 25 collaborators of Buqing Sai. A scholar is included among the top collaborators of Buqing Sai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Buqing Sai. Buqing Sai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kuang, Yingmin, Yu Huang, Jiaxin Niu, et al.. (2025). MTCH2 regulates NRF2-mediated RRM1 expression to promote melanoma proliferation and dacarbazine insensitivity. Cell Death and Disease. 16(1). 268–268.
2.
Fang, Yun, Lu Jiang, Zihan Yi, et al.. (2025). NDUFS3 promotes proliferation via glucose metabolism reprogramming inducing AMPK phosphorylating PRPS1 to increase the purine nucleotide synthesis in melanoma. Cell Death and Differentiation. 32(12). 2193–2209. 1 indexed citations
3.
Na, Tao, Buqing Sai, Ran Wei, et al.. (2025). A Readily Synthesized All‐In‐One Nanowire Hydrogel: Toward Inhibiting Tumor Recurrence and Postoperative Infection. Advanced Materials. 38(1). e08137–e08137. 1 indexed citations
4.
Liu, Wenjing, Xiangjie Liu, Asif Shahzad, et al.. (2025). A BRAF-activated noncoding RNA attenuates clear cell renal cell carcinoma via repression of glucose-6-phosphate dehydrogenase. Journal of Biological Chemistry. 301(3). 108247–108247.
6.
Wu, Na, Yun Fang, Junlin Xie, et al.. (2024). Molecular mechanisms of MAZ targeting up-regulation of NDUFS3 expression to promote malignant progression in melanoma. Communications Biology. 7(1). 1491–1491.
7.
Shahzad, Asif, Wenjing Liu, Xiangjie Liu, et al.. (2024). Flavonoids as modulators of metabolic reprogramming in renal cell carcinoma (Review). Oncology Reports. 52(6). 2 indexed citations
8.
Fang, Yun, Na Wu, Zhe Yang, et al.. (2024). NOD2 reduces the chemoresistance of melanoma by inhibiting the TYMS/PLK1 signaling axis. Cell Death and Disease. 15(10). 720–720. 3 indexed citations
9.
Yu, Feng, Lijuan Yang, Zihan Yi, et al.. (2022). NRF2-directed PRPS1 upregulation to promote the progression and metastasis of melanoma. Frontiers in Immunology. 13. 989263–989263. 6 indexed citations
10.
Fang, Yun, Feng Yu, Na Wu, et al.. (2022). Palmitic Acid Promotes Lung Metastasis of Melanomas via the TLR4/TRIF-Peli1-pNF-κB Pathway. Metabolites. 12(11). 1132–1132. 10 indexed citations
11.
Zheng, Leliang, Yinghong Zhu, Zheng Li, et al.. (2021). Lung microbiome alterations in NSCLC patients. Scientific Reports. 11(1). 11736–11736. 52 indexed citations
12.
Zhang, Qiao, Shujie Wang, Qiaoqiao Han, et al.. (2021). G6PD upregulates Cyclin E1 and MMP9 to promote clear cell renal cell carcinoma progression. International Journal of Medical Sciences. 19(1). 47–64. 10 indexed citations
13.
Wang, Lujuan, Peng Qiu, Buqing Sai, et al.. (2020). Ligand-independent EphB1 signaling mediates TGF-β-activated CDH2 and promotes lung cancer cell invasion and migration. Journal of Cancer. 11(14). 4123–4131. 17 indexed citations
14.
Zheng, Leliang, Jiaqi Xu, Buqing Sai, et al.. (2020). Microbiome Related Cytotoxically Active CD8+ TIL Are Inversely Associated With Lung Cancer Development. Frontiers in Oncology. 10. 531131–531131. 14 indexed citations
15.
She, Xiaoling, Yan Zhang, Changhong Liu, et al.. (2020). LRRC4 Suppresses E-Cadherin-Dependent Collective Cell Invasion and Metastasis in Epithelial Ovarian Cancer. Frontiers in Oncology. 10. 144–144. 15 indexed citations
16.
Zhang, Xina, Buqing Sai, Fan Wang, et al.. (2019). Hypoxic BMSC-derived exosomal miRNAs promote metastasis of lung cancer cells via STAT3-induced EMT. Molecular Cancer. 18(1). 40–40. 436 indexed citations breakdown →
17.
Sai, Buqing, Yafei Dai, Songqing Fan, et al.. (2019). Cancer-educated mesenchymal stem cells promote the survival of cancer cells at primary and distant metastatic sites via the expansion of bone marrow-derived-PMN-MDSCs. Cell Death and Disease. 10(12). 941–941. 55 indexed citations
18.
Cao, Pengfei, Meili Zhang, Lujuan Wang, et al.. (2018). miR-18a reactivates the Epstein-Barr virus through defective DNA damage response and promotes genomic instability in EBV-associated lymphomas. BMC Cancer. 18(1). 1293–1293. 16 indexed citations
19.
Cao, Pengfei, Meili Zhang, Wei Wang, et al.. (2017). Fluorescence in situ hybridization is superior for monitoring Epstein Barr viral load in infectious mononucleosis patients. BMC Infectious Diseases. 17(1). 323–323. 16 indexed citations
20.
Dai, Yafei, Lujuan Wang, Jingqun Tang, et al.. (2016). Activation of anaphase-promoting complex by p53 induces a state of dormancy in cancer cells against chemotherapeutic stress. Oncotarget. 7(18). 25478–25492. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026